SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,721 | +90.1% | 278 | +334.4% | 0.00% | – |
Q2 2023 | $3,009 | +37.9% | 64 | +23.1% | 0.00% | – |
Q1 2023 | $2,182 | +2.2% | 52 | -7.1% | 0.00% | – |
Q4 2022 | $2,136 | -76.3% | 56 | -76.0% | 0.00% | -100.0% |
Q3 2022 | $9,000 | +350.0% | 233 | +219.2% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 73 | +32.7% | 0.00% | -100.0% |
Q3 2021 | $2,000 | 0.0% | 55 | +37.5% | 0.00% | – |
Q2 2021 | $2,000 | -50.0% | 40 | -23.1% | 0.00% | -100.0% |
Q1 2021 | $4,000 | 0.0% | 52 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $4,000 | +33.3% | 52 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $3,000 | +50.0% | 52 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $2,000 | – | 52 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |